277 related articles for article (PubMed ID: 28211642)
1. Biomechanical Strain Exacerbates Inflammation on a Progeria-on-a-Chip Model.
Ribas J; Zhang YS; Pitrez PR; Leijten J; Miscuglio M; Rouwkema J; Dokmeci MR; Nissan X; Ferreira L; Khademhosseini A
Small; 2017 Apr; 13(15):. PubMed ID: 28211642
[TBL] [Abstract][Full Text] [Related]
2. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
Atchison L; Zhang H; Cao K; Truskey GA
Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
[TBL] [Abstract][Full Text] [Related]
3. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
4. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
[TBL] [Abstract][Full Text] [Related]
5. Vulnerability of progeroid smooth muscle cells to biomechanical forces is mediated by MMP13.
Pitrez PR; Estronca L; Monteiro LM; Colell G; Vazão H; Santinha D; Harhouri K; Thornton D; Navarro C; Egesipe AL; Carvalho T; Dos Santos RL; Lévy N; Smith JC; de Magalhães JP; Ori A; Bernardo A; De Sandre-Giovannoli A; Nissan X; Rosell A; Ferreira L
Nat Commun; 2020 Aug; 11(1):4110. PubMed ID: 32807790
[TBL] [Abstract][Full Text] [Related]
6. Direct reprogramming of human smooth muscle and vascular endothelial cells reveals defects associated with aging and Hutchinson-Gilford progeria syndrome.
Bersini S; Schulte R; Huang L; Tsai H; Hetzer MW
Elife; 2020 Sep; 9():. PubMed ID: 32896271
[TBL] [Abstract][Full Text] [Related]
7. Vascular disease modeling using induced pluripotent stem cells: Focus in Hutchinson-Gilford Progeria Syndrome.
Pitrez PR; Rosa SC; Praça C; Ferreira L
Biochem Biophys Res Commun; 2016 May; 473(3):710-8. PubMed ID: 26474704
[TBL] [Abstract][Full Text] [Related]
8. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Dysfunction in Hutchinson-Gilford Progeria Syndrome.
Kreienkamp R; Gonzalo S
Cells; 2020 Feb; 9(2):. PubMed ID: 32046343
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1.
Zhang H; Xiong ZM; Cao K
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):E2261-70. PubMed ID: 24843141
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?
Del Campo L; Hamczyk MR; Andrés V; Martínez-González J; Rodríguez C;
Clin Investig Arterioscler; 2018; 30(3):120-132. PubMed ID: 29602596
[TBL] [Abstract][Full Text] [Related]
12. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
13. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.
Nissan X; Blondel S; Peschanski M
Biochem Soc Trans; 2011 Dec; 39(6):1775-9. PubMed ID: 22103524
[TBL] [Abstract][Full Text] [Related]
14. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
Lo Cicero A; Nissan X
Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
[TBL] [Abstract][Full Text] [Related]
15. Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes.
Lo Cicero A; Saidani M; Allouche J; Egesipe AL; Hoch L; Bruge C; Sigaudy S; De Sandre-Giovannoli A; Levy N; Baldeschi C; Nissan X
Sci Rep; 2018 Jun; 8(1):9112. PubMed ID: 29904107
[TBL] [Abstract][Full Text] [Related]
16. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Varga R; Eriksson M; Erdos MR; Olive M; Harten I; Kolodgie F; Capell BC; Cheng J; Faddah D; Perkins S; Avallone H; San H; Qu X; Ganesh S; Gordon LB; Virmani R; Wight TN; Nabel EG; Collins FS
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3250-5. PubMed ID: 16492728
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle cell aging: Insights from Hutchinson-Gilford progeria syndrome.
Hamczyk MR; Nevado RM
Clin Investig Arterioscler; 2023; 35(1):42-51. PubMed ID: 35125249
[TBL] [Abstract][Full Text] [Related]
18. Substrate Topography Modulates Cell Aging on a Progeria Cell Model.
Pitrez PR; Estronca L; Vazão H; Egesipe AL; Le Corf A; Navarro C; Lévy N; De Sandre-Giovannoli A; Nissan X; Ferreira L
ACS Biomater Sci Eng; 2018 May; 4(5):1498-1504. PubMed ID: 33445307
[TBL] [Abstract][Full Text] [Related]
19. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
[TBL] [Abstract][Full Text] [Related]
20. An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria.
Lo CY; Tjong YW; Ho JC; Siu CW; Cheung SY; Tang NL; Yu S; Tse HF; Yao X
PLoS One; 2014; 9(1):e87273. PubMed ID: 24475260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
